Financial statements Polpharma Biologics Warsaw
Cash flow statement of Polpharma Biologics Warsaw
Company age:
Age:
11 y. 9 m. 6 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of POLPHARMA BIOLOGICS WARSAW
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Net cash from operating expenses | -5 934,00 | -6 880,00 | -67 592 418,59 | -136 026 531,08 |
| Net cash flow from investing activities | 5 952,00 | 6 920,00 | -115 788 244,17 | -95 754 549,85 |
| Net cash flow from financial activities | -18,00 | -1,00 | 216 486 638,85 | 243 268 487,08 |
| Total net cash flow | 0,00 | 39,00 | 33 105 976,09 | 11 487 406,15 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.